Depression in the Family of Patients With Dementia in Korea

Jang, Sung In; Bae, Hyerim; Shin, Jaeyong; Hong, Seri; Han, Kyu Tae; Park, Sohee

doi:10.1177/1533317515628048

Cited by 14 publications

(15 citation statements)

References 39 publications

(45 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Research regarding the difference of prevalence of depression among the sexes has shown that female caregivers exhibit more depressive symptoms than male caregivers. 9 , 26 That was not the case in our study, where the prevalence of depression among male and female caregivers did not show any significant difference. This may be because, in our experience, most caregivers in Saudi Arabia are the sons and daughters of the patients, and it is considered a cultural duty for the whole family to be involved in the care of their relatives with dementia.…”

Section: Discussioncontrasting

confidence: 69%

“… 8 In Korea, a study showed a clear association between being a caregiver to a patient with dementia and increased risk of depression, especially in women and low-income families. 9 Moreover, in Canada, female caregivers were found to be at higher risk of depressive symptoms than male caregivers. 10 In the United States, a study compared depressive symptoms between caregivers of patients with dementia and other diseases, and it revealed a higher risk in caregivers of patients with dementia, mainly in elderly caregivers.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Depression Among Caregivers of Patients With Dementia

Alfakhri

Alshudukhi

Alqahtani

et al. 2018

INQUIRY

View full text Add to dashboard Cite

We aimed to assess depressive symptoms in caregivers of patients with dementia, taking into account variables such as severity of dementia, sex, age, and financial state of the patient. We recruited 222 caregivers of patients with dementia from King Abdulaziz Medical City, Saudi Alzheimer’s Disease Association, and online, from February to June 2017, and employed the Patient Health Questionnaire to assess depression, and the Blessed Dementia Scale to assess severity of dementia. The prevalence of clinical depression among the caregivers was 14.9%. Minimal symptoms of depression were experienced by 96 caregivers (43.2%), moderate by 45 (20.3%), moderate-severe by 15 (6.8%), and severe by 8 (3.6%). Forty-six patients had mild dementia (22%), 73 had moderate (34.9%), and 90 had severe (43.1%). Caregivers of patients with dementia experience considerable burden and lower level of health-related quality of life and may be predisposed to developing clinical depression.

show abstract

Section: Discussioncontrasting

confidence: 69%

Section: Introductionmentioning

confidence: 99%

Depression Among Caregivers of Patients With Dementia

Alfakhri

Alshudukhi

Alqahtani

et al. 2018

INQUIRY

View full text Add to dashboard Cite

show abstract

“…The positive rate of PHQ-9-measured depressive symptoms was higher in the middle-aged family members of home-dwelling dementia patients (4.4%) than in the middle-aged family members in the control group (1.9%). A similar previous study using the KCHS data found that the prevalence of depression diagnosed by physicians who did not use a scale was higher in the family members of home-dwelling dementia patients (5.0%) compared to the control group (2.5%) [20]. In addition, a study using the data from the 2012 and 2013 National Health and Wellness Survey, an online survey, in Japan with a PHQ-9 cut-off score of 10 points found that the positive rate of depressive symptoms was higher in the family members of home-dwelling dementia patients (14.2%) compared to the non-caregivers in the control group (8.6%) [21].…”

Section: Discussionsupporting

confidence: 51%

Characteristic of depressive symptom in middle-aged family members with Dementia patient : 2017 Korea Community Health Survey

et al. 2020

View full text Add to dashboard Cite

METHODS: This study used the data from the nationwide 2017 Korea Community Health Survey. Among the 228,381 survey participants, 77,276 participants in their 40s and 50s were finally selected for this study. The participants consisted of 760 family members of home-dwelling dementia patients and 76,516 general family members comprising a control group. RESULTS: The positive rate of Patient Health Questionnaire-9 (PHQ-9)-measured depressive symptoms was significantly higher in the family members of home-dwelling dementia patients (4.4%; control group: 1.9%). After adjusting for potential confounders, the prevalence of PHQ-measured depressive symptoms was 1.72 times (95% confidence interval [CI], 1.03 to 2.85) higher in the family members of home-dwelling dementia patients compared to the control group. The positive rate of depressive symptoms was 2.26 times higher (95% CI, 1.26 to 4.05) in the female middle-aged family members of home-dwelling dementia patients compared to the control group. In addition, those who reported having symptoms almost every day in the PHQ-9 questions had significantly higher positive rates on questions about loss of interest, depression, sleep disturbance, fatigue, poor appetite, and suicidal ideation, and not on questions regarding feelings of worthlessness and psychomotor agitation, compared to the control group. CONCLUSIONS: Active interventions are needed to relieve depression in the family members of home-dwelling dementia patients.

show abstract

“…Similarly, a recent systematic review and meta-analysis found that the prevalence of depression among caregivers was 34.0%, anxiety 43.6%, and use of psychotropic drugs 27.2%, with increased probability of depression in female and spousal caregivers [110]. Notably, female caregivers of ADRD patients are more likely to develop depression than male caregivers [110,117]…”

Section: Informal Caregivers Report Poorer Health Status and Greater mentioning

confidence: 96%

Tip of the Iceberg: Assessing the Global Socioeconomic Costs of Alzheimer’s Disease and Related Dementias and Strategic Implications for Stakeholders

El-Hayek¹,

Wiley

Khoury³

et al. 2019

JAD

158

126

View full text Add to dashboard Cite

While it is generally understood that Alzheimer's disease (AD) and related dementias (ADRD) is one of the costliest diseases to society, there is widespread concern that researchers and policymakers are not comprehensively capturing and describing the full scope and magnitude of the socioeconomic burden of ADRD. This review aimed to 1) catalogue the different types of AD-related socioeconomic costs described in the literature; 2) assess the challenges and gaps of existing approaches to measuring these costs; and 3) analyze and discuss the implications for stakeholders including policymakers, healthcare systems, associations, advocacy groups, clinicians, and researchers looking to improve the ability to generate reliable data that can guide evidence-based decision making. A centrally emergent theme from this review is that it is challenging to gauge the true value of policies, programs, or interventions in the ADRD arena given the long-term, progressive nature of the disease, its insidious socioeconomic impact beyond the patient and the formal healthcare system, and the complexities and current deficiencies (in measures and real-world data) in accurately calculating the full costs to society. There is therefore an urgent need for all stakeholders to establish a common understanding of the challenges in evaluating the full cost of ADRD and define approaches that allow us to measure these costs more accurately, with a view to prioritizing evidence-based solutions to mitigate this looming public health crisis.

show abstract

Depression in the Family of Patients With Dementia in Korea

Cited by 14 publications

References 39 publications

Depression Among Caregivers of Patients With Dementia

Depression Among Caregivers of Patients With Dementia

Characteristic of depressive symptom in middle-aged family members with Dementia patient : 2017 Korea Community Health Survey

Tip of the Iceberg: Assessing the Global Socioeconomic Costs of Alzheimer’s Disease and Related Dementias and Strategic Implications for Stakeholders

Contact Info

Product

Resources

About